FDA, NIH collaborate on AE reporting

Share this article:

The FDA and the NIH have agreed to develop a harmonized adverse event (AE) reporting mechanism for consumers, health professionals, investigators, sponsors and other parties to electronically submit reports.

The project is aimed at developing a “Rational Questionnaire” and electronic prototype system for reporting. The questionnaire is intended to be an “interactive help system” that will assist AE reporters in determining which data need to be submitted and to whom. The prototype system will allow the agencies to test the feasibility of a central, federal web-based portal to provide direct, seamless, online submission of adverse event reports to appropriate agencies.

A harmonized reporting system would reduce the amount of reporting by clinical investigators, according to the MOU. Currently investigators must submit separate AE reports to multiple agencies using different forms.

“Oversight bodies and agencies receiving this information are often faced with tremendous volumes of data reported in idiosyncratic ways, which often frustrates efforts to conduct meaningful aggregations and analyses of data, or to cull from reports information key to important safety concerns,” the MOU explains.

A joint Federal Adverse Event Task Force has been formed and they are tasked with developing a consensus standard for adverse event reporting called the Basal Adverse Event Report. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?